EUVIMEDPoznaj EUVIMED
Crossref

In Vitro Drug Metabolism Using Liver Microsomes

Kathleen M Knights, David M Stresser, John O Miners, Charles L Crespi

Current Protocols in Pharmacology · 2016-09 · 74 (1)

DOI: 10.1002/cpph.9 ↗

At a glance

Journal article in Current Protocols in Pharmacology, published online on 2016-09-16. Written by Kathleen M Knights and 3 co-authors. Institution: Department of Clinical Pharmacology, School of Medicine, Flinders University, Adelaide, South Australia, Australia. Cited 108 times so far (Crossref); 52 references.

AbstraktSubjectsDane bibliograficzneCiteRelated studies

Abstract (original language)

Knowledge of the metabolic stability of newly discovered drug candidates eliminated by metabolism is essential for predicting the pharmacokinetic (PK) parameters that underpin dosing and dosage frequency. Further, characterization of the enzyme(s) responsible for metabolism (reaction phenotyping) allows prediction, at least at the qualitative level, of factors (including metabolic drug‐drug interactions) likely to alter the clearance of both new chemical entities (NCEs) and established drugs. Microsomes are typically used as the enzyme source for the measurement of metabolic stability and for reaction phenotyping because they express the major drug‐metabolizing enzymes cytochrome P450 (CYP) and UDP‐glucuronosyltransferase (UGT), along with others that contribute to drug metabolism. Described in this unit are methods for microsome isolation, as well as for the determination of metabolic stability and metabolite formation (including kinetics). © 2016 by John Wiley & Sons, Inc.

Subjects

MeSH terms (MEDLINE)

AnimalsChromatography, High Pressure LiquidCytochrome P-450 Enzyme SystemDrug DiscoveryGlucuronosyltransferaseHigh-Throughput Screening AssaysHumansMicrosomes, LiverPharmaceutical PreparationsTandem Mass SpectrometryZidovudine

Author keywords

in vitro drug metabolismliver microsomesmetabolic stabilitymicrosome isolation

Substances

Pharmaceutical PreparationsZidovudineCytochrome P-450 Enzyme SystemGlucuronosyltransferase

Authors and institutions

  • Department of Clinical Pharmacology, School of Medicine, Flinders University, Adelaide, South Australia, Australia.
  • Corning Gentest Contract Research, Corning Incorporated Life Sciences, Woburn, Massachusetts.
  • Department of Clinical Pharmacology and Flinders Centre for Innovation in Cancer, School of Medicine, Flinders University, Adelaide, South Australia, Australia.
  • Corning Incorporated, Tewksbury, Massachusetts.

Cite

APA

Knights, K. M., Stresser, D. M., Miners, J. O., & Crespi, C. L. (2016). In Vitro Drug Metabolism Using Liver Microsomes. Current Protocols in Pharmacology, 74(1). https://doi.org/10.1002/cpph.9

Vancouver

Knights KM, Stresser DM, Miners JO, Crespi CL. In Vitro Drug Metabolism Using Liver Microsomes. Current Protocols in Pharmacology. 2016;74(1). doi:10.1002/cpph.9

BibTeX
@article{Knights2016,
  author = {Knights, Kathleen M and Stresser, David M and Miners, John O and Crespi, Charles L},
  title = {In Vitro Drug Metabolism Using Liver Microsomes},
  journal = {Current Protocols in Pharmacology},
  year = {2016},
  volume = {74},
  number = {1},
  doi = {10.1002/cpph.9}
}
Start for free →